News Focus
News Focus
icon url

Mortimerduke

06/08/23 9:07 PM

#599942 RE: dmb2 #599939

Thumbs down to partner or buy-out. Our management has all the ability to get NWBO products to market. They have overcome the attacks of the scum & demonic marauders sponsored by the big money and should not turn over the fruits of their labor to them. I support our management and my NWBO investment was based on them.
Bullish
Bullish
icon url

ATLnsider

06/08/23 9:45 PM

#599948 RE: dmb2 #599939

Thank you for your reply dmb2.
Bullish
Bullish
icon url

biosectinvestor

06/09/23 12:29 AM

#599963 RE: dmb2 #599939

I agree. The pathway for them is approval for GBM, and expansion of the label, which is now very easy given new regulations. Why would they create a massive, novel bill to climb for themselves by going for an “agnostic approval”. That doesn’t even make the vaguest sense from a regulatory perspective. It’s not going to happen.

But validation of the MOA is a critical piece of the basic approval. It will be very compelling and sets the stage well for the next approvals and expanding the label rapidly, as rapidly as is practically possible.

Thanks for the great, careful post.